Leonteq Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Leonteq Securities's REGN Position: Q3 2026 in Review
Leonteq Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 75% in Q3 2026, selling an estimated $2.22M and leaving 1,005 shares worth $762K. The position accounts for 0.03% of the portfolio, ranked #271.
Leonteq Securities first reported a position in REGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $4.76M in Q1 2021. 1,431 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Leonteq Securities held 1,005 shares of Regeneron Pharmaceuticals worth $762K as of Q3 2026.
- Leonteq Securities sold 2,943 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $2.22M.
- Regeneron Pharmaceuticals made up 0.03% of Leonteq Securities's portfolio in Q3 2026, its #271 holding.
- Leonteq Securities first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's Regeneron Pharmaceuticals position peaked at $4.76M in Q1 2021.
- 1,431 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.